# K102074: Powder Free Nitrile Examination Gloves, Tested for Use with Chemotherapy Drugs, Blue (SG)

- Pathway: 510(k) (Traditional)
- Applicant: Gx Corporation Sdn Bhd
- Decided: Nov 2, 2010 after 99 days
- Product code: LZA (Polymer Patient Examination Glove)
- Device class: 1
- Regulation: 21 CFR 880.6250
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
No later device cites it as a predicate yet.
0 of 1 device in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names no predicate by number.

## Indications for use
This glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. This glove has been tested for use with specific chemotherapy drugs listed below. Chemotherapy Drug Permeation (Breakthrough Detection Time in Minutes) Dacarbazine (DTIC) (10.0 mg/mL) — > 240 Mitomycin C (5.0 mg/mL) — > 240 Carmustine (BCNU) (3.3 mg/mL) — 3.48 Cyclophosphamide (Cytoxan) (20.0 mg/mL) — > 240 Doxorubicin Hydrochloride (2.0 mg/mL) — > 240 5-Fluorouracil (50.0 mg/mL) — > 240 Cisplatin (1.0 mg/mL) — > 240 Etoposide (20.0 mg/mL) — > 240 Paclitaxel (Taxol) (6.0 mg/mL) — > 240 Thio-Tepa (10.0 mg/mL) — 2.97 Vincristine Sulfate (50.0 mg/mL) — > 240 Methotrexate (25.0 mg/mL) — > 240 Mitoxantrone (100.0 mg/mL) — > 240 Ifosfamide (Ifex) (50.0 mg/mL) — > 240 Please note that the following drugs; Carmustine and Thio-Tepa have extremely low permeation time of 3.48 and 2.97 minutes.

Source page: https://510kreport.com/device/K102074
Methodology: https://510kreport.com/methodology